如何治疗长期低躁狂发作的主要抑郁症? 一个案例报告报告
Jiashu Yao1, Shenpang Wang1,2, Yifei Li1
1Department of Psychiatry, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Frontiers in psychiatry
|July 30, 2024
概括
这项案例研究强调,与低躁狂发作相关的大型抑郁症可能表明双相情感障碍. 情绪稳定剂和非典型的抗精神病药物可能比抗抑郁药对这些患者更有效.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 临床案例研究临床案例研究
背景情况:
- 重度抑郁障碍 (MDD) 伴有较短时间的低躁狂发作,存在诊断方面的挑战.
- 在这种情况下,抗抑郁药单一治疗可能是无效的,甚至是破坏稳定的.
- COVID-19 流行病已与各种神经和精神疾病表现有关.
研究的目的:
- 举报一个案例,说明从MDD的诊断演变与hypomanic特征双相情感障碍.
- 在这种情况下,探索情绪稳定剂和非典型抗精神病药物的疗效.
- 讨论双相情感障碍的概念化作为一个频谱.
主要方法:
- 一个61岁的女性患者的病例报告.
- 对治疗史的审查,包括不有效的抗抑郁药的使用.
- 在COVID-19感染后观察临床变化.
- 对情绪稳定剂和非典型抗精神病药物的治疗反应的评估.
主要成果:
- 最初被诊断为MDD的患者在低躁狂发作后表现出持续的症状.
- 在COVID-19感染后,她的演讲符合双相情感障碍的标准.
- 用情绪稳定剂和非典型抗精神病药物治疗导致了持续的临床改善.
- 抗抑郁药在控制她的抑郁和低躁症症状方面无效.
结论:
- 双极性障碍可能存在于连续频谱上,而不是严格的二进制.
- 患有MDD和短期低躁狂发作的患者可能比抗抑郁药更受益于情绪稳定剂和非典型抗精神病药物.
- 这一案例强调了对精神病的诊断重新评估的重要性,尤其是在病毒感染等重大生理事件后.
相关概念视频
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:30Bipolar Disorder
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.